Regenxbio Inc (RGNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 28,914 | 19,977 | 19,138 | 31,345 | 26,512 |
| Cost of Goods | 12,388 | 9,475 | 4,112 | 12,783 | 13,094 |
| Gross Profit | 16,526 | 10,502 | 15,026 | 18,562 | 13,418 |
| Operating Expenses | 81,874 | 84,085 | 81,295 | 77,116 | 84,557 |
| Operating Income | -64,960 | -73,108 | -66,157 | -57,771 | -71,045 |
| Interest Expense | 1,624 | 1,120 | 2,755 | 4,310 | 5,954 |
| Other Income | 4,716 | 2,167 | 2,236 | 2,103 | 1,515 |
| Pre-tax Income | -61,868 | -72,061 | -66,676 | -59,978 | -75,484 |
| Income Tax | N/A | N/A | N/A | -43 | N/A |
| Net Income Continuous | -61,868 | -72,061 | -66,676 | -59,935 | -75,484 |
| Net Income | $-61,868 | $-72,061 | $-66,676 | $-59,935 | $-75,484 |
| EPS Basic Total Ops | -1.41 | -1.66 | -1.53 | -1.38 | -1.75 |
| EPS Basic Continuous Ops | -1.41 | -1.66 | -1.53 | -1.38 | -1.75 |
| EPS Diluted Total Ops | -1.41 | -1.66 | -1.53 | -1.38 | -1.75 |
| EPS Diluted Continuous Ops | -1.41 | -1.66 | -1.53 | -1.38 | -1.75 |
| EBITDA(a) | $-60,721 | $-68,293 | $-61,297 | $-52,742 | $-66,365 |